Key result
DCB angioplasty shows promise as a feasible treatment strategy for STEMI complicated by coronary aneurysms.
Why the study?
STEMI with a coronary aneurysm is rare and its treatment approach remains not well established.
Does a drug-coated balloon-only strategy successfully treat STEMI with right coronary aneurysm?
Does a drug-coated balloon-only strategy successfully treat STEMI with right coronary aneurysm?
Drug-coated balloon angioplasty may be considered as a viable treatment strategy for STEMI patients presenting with coronary aneurysms.
Answers are grounded in this paper and cite their sources.
May be feasible in STEMI with aneurysm; hypothesis-generating and should not yet change practice.
ST-segment elevation myocardial infarction (STEMI) with a coronary aneurysm is rare; therefore, its treatment approach remains not well established. This case suggests that drug-coated balloon angioplasty may be considered for STEMI patients with coronary aneurysms.
No takes yet. Share an insight, caveat, or question.
Yu Sugawara (2025) studied this question. Drug-coated balloon angioplasty may be considered as a treatment strategy for patients presenting with ST-segment elevation myocardial infarction complicated by coronary aneurysms.
Synapse has enriched 10 related papers. Consider them for comparative context: